Startup Fundraising

Holifya Raises €2M for AI Obesity Clinic

Holifya secures €2 million in funding led by Next Age (CDP Venture Capital) to expand its AI-powered digital clinic for obesity and metabolic disorders.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Healthcare, Healthtech & Medtech in Italy" are published.

Key Takeaways

  • Holifya raised $2.0M (Series A) from CDP Venture Capital, Next Age, AC75 Startup Accelerator, Growth Engine, Doorway, 20Fund, Zooga VC.
  • Sector: Healthcare, Healthtech & Medtech.
  • Geography: Italy.

Analysis

Holifya, an innovative digital clinic focused on tackling obesity and metabolic disorders through advanced technology, has successfully closed a €2 million funding round. This significant capital injection, comprising €1.6 million in equity and an additional €400,000 in debt and grants, will fuel the company's expansion and further development of its AI-powered treatment protocols.

The funding initiative was spearheaded by Next Age, a specialized program under CDP Venture Capital's National Accelerators Network, designed to foster innovation in the Silver Economy. This strategic backing highlights the growing investor interest in digital health solutions addressing chronic conditions prevalent in aging populations. The broader market for digital therapeutics, particularly in chronic disease management, is experiencing robust growth, projected to reach tens of billions globally in the coming years.

Joining Next Age in this crucial funding round were several key investors, demonstrating strong confidence in Holifya's vision and execution. These include existing supporter Growth Engine, alongside new participants Doorway, 20Fund (represented by GP Serra Elizabeth Falke), and Zooga VC. A number of angel investors also contributed, underscoring the broad appeal of Holifya's mission to revolutionize obesity care.

Since its inception, Holifya has now raised over €2.5 million, a testament to its progress and market potential. The company differentiates itself by integrating artificial intelligence and advanced diagnostics into its treatment plans, offering personalized and data-driven approaches to patient care. This focus on technology is critical in a sector where traditional methods often struggle with long-term patient engagement and adherence.

With this new capital, Holifya aims to significantly scale its operations. The company plans to expand its team, targeting an increase to over 60 employees by the end of the year. This growth will support the enhancement of its digital platform, the expansion of its clinical services, and potentially new market entries. The digital health sector, especially in areas like chronic disease management, continues to attract substantial investment as healthcare systems worldwide seek more efficient and effective solutions.

Holifya's model addresses a critical unmet need. Obesity is a complex global health challenge, with significant economic and social costs. By leveraging technology, Holifya is positioned to offer a scalable and accessible solution, potentially improving health outcomes for millions and reducing the burden on healthcare systems. The company's success in securing this funding round signals a positive trajectory for digital health innovation in Italy and beyond.